About MicroProtein Technologies

About Us

A Pioneer In The Field Of Biotechnology

MicroProtein Technologies Inc. (MPT) is a pioneer in the field of biotechnology, offering CMO services using MPTxpress, a unique solid-state/liquids- and stress-free E. coli. manufacturing platform; and commercializing antibody affinity proteins and resins with greatly improved pH tolerance. Using our patented MPTxpress technology, we aim to lead the industry in the production of microbially-expressed recombinant proteins, enzymes and plasmid DNA for use in biopharmaceuticals, diagnostics, reagents, veterinary medicine, non-clinical academic and industrial applications.

Our New Location

MicroProtein Technologies moved to new facilities in Jan. 2014 that providing research and through cGMP commercial manufacturing MPTxpress and other CRO and CMO services. The new facilities also enabled expansion of CMO bioprocessing and affinity resins production.

Our Story

About the Company

MicroProtein Technologies Inc. (MPT) is a pioneer in the field of biotechnology, offering Microbial / E.coli CDMO , CRO and CMO services using MPTxpress, a unique solid-state/liquid-free and stress-free E.coli manufacturing platform; and commercializing recombinant proteins and other antibody affinity proteins. Using our patented MPTxpress technology, we aim to lead the industry in the production of microbially-expressed recombinant proteins, antibody fragments, enzymes and plasmid DNA for use in biopharmaceuticals for clinical / commercial use, diagnostics, reagents, veterinary medicine, non-clinical, academic and industrial applications.

Read more about our novel upstream and fermentation process in our feature in BioProcess International here and in Genetic Engineering Biotechnology News here